NCT05693168

Brief Summary

Clinical evaluation of the accuracy of SpO2 measurements with the ANNE Limb Sensor compared to blood gas analysis in healthy, adult subjects. Hypoxia is induced in patients to different and stable levels of SaO2 over the range of 70-100%.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 23, 2021

Completed
1 day until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 24, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 24, 2021

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

December 27, 2022

Completed
24 days until next milestone

First Posted

Study publicly available on registry

January 20, 2023

Completed
Last Updated

January 20, 2023

Status Verified

January 1, 2023

Enrollment Period

1 day

First QC Date

December 27, 2022

Last Update Submit

January 12, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • ARMS of SpO2 Measurements with ANNE Limb compared to SaO2

    Root mean square error between the function blood oxygen saturation (SpO2) provided by the device under test and the blood gas analysis of oxyhemoglobin saturation (SaO2)

    1 hour

Study Arms (1)

Comparison of ANNE Limb Sensor pulse oximetry measurements to blood gas analysis

EXPERIMENTAL
Device: ANNE Limb Sensor

Interventions

Pulse Oximeter

Comparison of ANNE Limb Sensor pulse oximetry measurements to blood gas analysis

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • The subject is male or female, between the ages of 18 and 55 years.
  • The subject is in good general health with no evidence of any medical problems
  • The subject is fluent in both written and spoken English
  • The subject has provided informed consent and is willing to comply with the study procedures.

You may not qualify if:

  • Known history of heart disease, lung disease, kidney or liver disease
  • Diagnosis of asthma, sleep apnea, or use of CPAP
  • Subject has diabetes
  • Subject has a clotting disorder
  • The subject has a hemoglobinopathy or history of anemia, per subject report or the first blood sample, that in the opinion of the investigator, would make them unsuitable for study participation
  • The subject has any other serious systemic illness
  • Th subject is a current smoker
  • Any injury, deformity, or abnormality at the sensor sites that in the opinion of the investigators would interfere with the sensors working correctly
  • The subject has a history of fainting or vasovagal response
  • The subject has a history of sensitivity to local anesthesia
  • The subject has a diagnosis of Raynaud's disease
  • The subject has unacceptable collateral circulation based on exam by the investigator (Allen's test)
  • The subject is pregnant, lactating, or trying to get pregnant
  • The subject is unable or unwilling to provide informed consent, or is unable or unwilling to comply with study procedures
  • The subject has any other condition, which in the opinion of the investigators would make them unsuitable for the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hypoxia Research Laboratory Department of Anesthesia and Perioperative Care University of California, San Francisco

San Francisco, California, 94143, United States

Location

MeSH Terms

Conditions

Hypoxia

Condition Hierarchy (Ancestors)

Signs and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 27, 2022

First Posted

January 20, 2023

Study Start

June 23, 2021

Primary Completion

June 24, 2021

Study Completion

June 24, 2021

Last Updated

January 20, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

Locations